Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 10616
  • Home
  • Print this page
  • Email this page

    Article Cited by others


The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration

Azad Rajvardhan, Chandra Parijat, Gupta Ritesh

Year : 2007| Volume: 55| Issue : 6 | Page no: 441-443

   This article has been cited by
1 Effects of core vitrectomy in the treatment of age-related macular degeneration
Katharina Schramm,Michael Mueller,Frank H. Koch,Pankaj Singh,Thomas Kohnen,Michael J. Koss
Acta Ophthalmologica. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
2 Does DcR1 (TNF-related apoptosis-inducing-ligand Receptor 3) have any role in human AMD pathogenesis?
Akshay Anand,Neel K. Sharma,Ramandeep Singh,Amod Gupta,Sudesh Prabhakar,Neeru Jindal,Arvind K. Bhatt,Suresh K. Sharma,Pawan K. Gupta
Scientific Reports. 2014; 4
[Pubmed]  [Google Scholar] [DOI]
3 Safety of Submacular Suprachoroidal Drug Administration via a Microcatheter: Retrospective Analysis of European Treatment Results
Manfred Tetz, Stanislao Rizzo, Albert J. Augustin
Ophthalmologica. 2012; 227(4): 183
[HTML Full text]  [Google Scholar] [DOI]
4 New Biomarker for Neovascular Age-Related Macular Degeneration: Eotaxin-2
Neel Kamal Sharma,Sudesh Prabhakar,Amod Gupta,Ramandeep Singh,Pawan Kumar Gupta,Pramod Kumar Gupta,Akshay Anand
DNA and Cell Biology. 2012; 31(11): 1618
[Pubmed]  [Google Scholar] [DOI]
5 Quadruple Therapy Leads to a Sustained Improvement of Vision in Patients with Wet Age-Related Macular Degeneration
Michael J. Koss, Aneta Lewicka-Chomont, Katharina Schramm, Robert Rejdak, Christian Ohrloff, Frank H. Koch
Ophthalmologica. 2011; 226(2): 45
[HTML Full text]  [Google Scholar] [DOI]
6 Combined intravitreal pharmacosurgery in patients with occult choroidal neovascularization secondary to wet age-related macular degeneration
Koss, M.J., Scholtz, S., Haeussler-Sinangin, Y., Singh, P., Koch, F.H.
Ophthalmologica. 2010; 224(2): 72-78
[Pubmed]  [Google Scholar]
7 Bevacizumab for neovascular age related macular degeneration (ABC Trial): Multicentre randomised double masked study
Tufail, A., Patel, P.J., Egan, C., Hykin, P., Da Cruz, L., Gregor, Z., Dowler, J., (...), Xing, W.
BMJ. 2010; 340(7761): 1398
[Pubmed]  [Google Scholar]
8 Age-related macular degeneration: A case study
Kerr, E.
British Journal of Nursing. 2010; 19(11): 693-697
[Pubmed]  [Google Scholar]
9 Intravitreal bevacizumab in pigmented rabbit eyes: Histological analysis 90 days after injection | [Bevacizumabe intravítreo em olhos de coelhos não albinos: Análise histológica 90 dias após a injeção]
Arraes, J.C., Tedesco, R.C., Arraes, T.A., da Silva, E.B., Ventura, A., de Ávila, M.P.
Arquivos Brasileiros de Oftalmologia. 2009; 72(5): 655-660
[Pubmed]  [Google Scholar]
10 Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration
Focke Ziemssen,Salvatore Grisanti,Karl Ulrich Bartz-Schmidt,Martin S. Spitzer
Drugs & Aging. 2009; 26(4): 295
[Pubmed]  [Google Scholar] [DOI]
11 Off with the label and on the Avastin bandwagon: Why now and how far
Santhan Gopal, K.S.
Indian Journal of Ophthalmology. 2009; 57(4): 253-256
[Pubmed]  [Google Scholar]
12 Off-label use of bevacizumab for the treatment of age-related macular degeneration: What is the evidence?
Ziemssen, F., Grisanti, S., Bartz-Schmidt, K.U., Spitzer, M.S.
Drugs and Aging. 2009; 26(4): 295-320
[Pubmed]  [Google Scholar]
13 Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration
Shah, G.K., Sang, D.N., Hughes, M.S.
Retina. 2009; 29(2): 133-148
[Pubmed]  [Google Scholar]
Retina. 2009; 29(2): 133
[Pubmed]  [Google Scholar] [DOI]
15 Ranibizumab (Lucentis{\textregistered}) en degeneraci{\æo}n macular asociada a la edad (DMAE). Nuestra experiencia
Archivos de la Sociedad Canaria de Oftalmolog{\æ\i. 2008; : 26
[Pubmed]  [Google Scholar]


Read this article